Clinical trial Recruiting at 1 site Interventional Ages 15 and up

Using pasteurized donor human milk for infants exposed to HIV

Official title: Pasteurized Donor Human Milk for HIV-Exposed Infants: A Pilot Study

Run by University of Saskatchewan · NCT06955715 · Data updated 2026-11-12

This study tests if giving pasteurized donor human milk to infants exposed to HIV is a good alternative to formula feeding for their health and nutrition.

Quick facts

Study typeInterventional
Ages15 Years and up
SexAll
Enrollment10 (estimated)
SponsorUniversity of Saskatchewan
Academic / other
Locations1 site (Saskatoon, Saskatchewan)
StatusRecruiting
StartedApril 15, 2025
Main results expectedMay 1, 2026
Study endsDecember 31, 2026
Registry record updatedNovember 19, 2025
Trial IDNCT06955715 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women aged 15 and older living with HIV who have recently given birth or are primary caregivers of HIV-exposed infants.

Probably not a fit

Patients who are not living with HIV or whose infants are not exposed to HIV may not receive any benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study aims to evaluate the feasibility of providing pasteurized donor human milk (PDHM) to infants exposed to HIV, as an alternative to formula feeding. Participants will include women living with HIV who have recently given birth or caregivers of HIV-exposed infants, residing in Saskatoon, Canada. Over a period of 6-8 weeks, PDHM will be delivered to participants' homes, and caregivers will track feeding habits and any challenges encountered. The study seeks to assess the nutritional and immunological benefits of PDHM for this vulnerable population.

Why it matters

Potential benefit: If successful, this approach could improve health outcomes for HIV-exposed infants by providing them with the immunological benefits of human milk.

How similar studies have gone: While the use of PDHM in neonatal intensive care units has shown success, its application for HIV-exposed infants is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria

* ≥15 years of age
* Pregnant or recently gave birth and living with HIV or is the primary caregivers of an HIV-exposed infant
* Being followed by SHA Pediatric Infectious Disease
* Saskatchewan resident (living within \~150 km from the University of Saskatchewan)
* Have a household freezer
* Willing to participate

Where it's running

  • University of Saskatchewan
    Saskatoon, Saskatchewan, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.